[HTML] frontiersin.org

[HTML][HTML] The research progress of trastuzumab-induced cardiotoxicity in HER-2-positive breast cancer treatment

M Lin, W Xiong, S Wang, Y Li, C Hou, C Li… - Frontiers in …, 2022 - frontiersin.org
In recent years, the incidence of breast cancer has been increasing on an annual basis.
Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human …
被引用次数：37 相关文章
[HTML] frontiersin.org

[HTML][HTML] The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment

M Lin, W Xiong, S Wang, Y Li, C Hou, C Li… - Frontiers in …, 2022 - frontiersin.org
In recent years, the incidence of breast cancer has been increasing on an annual basis.
Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human …

The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment

M Lin, W Xiong, S Wang, Y Li… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
In recent years, the incidence of breast cancer has been increasing on an annual basis.
Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human …
[HTML] nih.gov

[HTML][HTML] The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment

M Lin, W Xiong, S Wang, Y Li, C Hou… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
In recent years, the incidence of breast cancer has been increasing on an annual basis.
Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human …

The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment.

M Lin, W Xiong, S Wang, Y Li, C Hou… - Frontiers in …, 2022 - europepmc.org
In recent years, the incidence of breast cancer has been increasing on an annual basis.
Human epidermal growth factor receptor-2 (HER-2) is overexpressed in 15-20% human …